A2M & BUB not going higher whereas we are the stand out. I like what I see in here. Hopefully the negative correlation between those 3 stocks are getting more clear. We are the next one getting CFDA. Mr market, wakey wakey
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025